Asian Phytoceuticals PCL (BKK:APCO)

Asian Phytoceuticals PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	204.02	210.83	292.76	250.38	223.35	247.73
Revenue Growth (YoY)	-22.81%	-27.99%	16.93%	12.10%	-9.84%	0.03%
Cost of Revenue	37.91	40.96	57.25	47.94	46.26	52.87
Gross Profit	166.11	169.87	235.52	202.44	177.09	194.85
Selling, General & Admin	122.31	120.1	119.72	116.49	106.29	124.73
Other Operating Expenses	-3.35	-3.34	-1.09	-2.08	-3.03	-5.41
Operating Expenses	118.96	116.76	118.63	114.41	103.27	119.32
Operating Income	47.15	53.11	116.89	88.03	73.82	75.53
Interest Expense	-1.64	-1.59	-0.66	-0.57	-0.86	-0.48
Interest & Investment Income	11.42	13.05	15.22	12.41	10.31	4.41
Earnings From Equity Investments	1.52	1.67	1.26	0.61	-0.28	-0.01
EBT Excluding Unusual Items	58.45	66.24	132.72	100.48	82.98	79.45
Gain (Loss) on Sale of Investments	4.75	1.73	0.47	-0.01	2.51	7.61
Pretax Income	63.21	67.98	133.18	100.47	85.49	87.07
Income Tax Expense	11.51	12.21	24.45	19.28	16.79	17.09
Earnings From Continuing Operations	51.7	55.77	108.74	81.2	68.7	69.98
Minority Interest in Earnings	-0.93	-1.06	-1.24	-0.28	-	-
Net Income	50.77	54.71	107.49	80.92	68.7	69.98
Net Income to Common	50.77	54.71	107.49	80.92	68.7	69.98
Net Income Growth	-44.47%	-49.10%	32.84%	17.78%	-1.82%	20.85%
Shares Outstanding (Basic)	620	601	601	600	600	600
Shares Outstanding (Diluted)	620	601	601	600	600	600
Shares Change (YoY)	5.59%	0.12%	0.11%	-0.03%	-0.02%	0.01%
EPS (Basic)	0.08	0.09	0.18	0.13	0.11	0.12
EPS (Diluted)	0.08	0.09	0.18	0.13	0.11	0.12
EPS Growth	-47.41%	-49.16%	32.69%	17.82%	-1.80%	20.83%
Free Cash Flow	28.42	35.36	120.72	99.86	83.22	82.57
Free Cash Flow Per Share	0.05	0.06	0.20	0.17	0.14	0.14
Dividend Per Share	0.092	0.092	0.180	0.155	0.123	0.120
Dividend Growth	-48.89%	-48.89%	16.13%	25.61%	2.83%	26.32%
Gross Margin	81.42%	80.57%	80.45%	80.85%	79.29%	78.66%
Operating Margin	23.11%	25.19%	39.93%	35.16%	33.05%	30.49%
Profit Margin	24.88%	25.95%	36.72%	32.32%	30.76%	28.25%
Free Cash Flow Margin	13.93%	16.77%	41.24%	39.88%	37.26%	33.33%
EBITDA	53	59.29	123.69	94.84	81.48	87.51
EBITDA Margin	25.98%	28.12%	42.25%	37.88%	36.48%	35.32%
D&A For EBITDA	5.85	6.18	6.8	6.81	7.66	11.97
EBIT	47.15	53.11	116.89	88.03	73.82	75.53
EBIT Margin	23.11%	25.19%	39.93%	35.16%	33.05%	30.49%
Effective Tax Rate	18.21%	17.96%	18.36%	19.19%	19.64%	19.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.